Lenvatinib Mesylate and Pneumococcal Conjugate Vaccine (7-Valent)
Determining the interaction of Lenvatinib Mesylate and Pneumococcal Conjugate Vaccine (7-Valent) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
Generic Name: pneumococcal 7-valent vaccine
Brand name: Prevnar
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib Mesylate-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Lenvatinib Mesylate-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Lenvatinib Mesylate-Pneumovax 23
- Lenvatinib Mesylate-PNV - Omega
- Lenvatinib Mesylate-PNV Iron Polysaccharides, Folic Acid, DHA
- Lenvatinib Mesylate-PNV OB with DHA
- Pneumococcal Conjugate Vaccine (7-Valent)-Lenvima
- Pneumococcal Conjugate Vaccine (7-Valent)-Lenvima (14 MG Daily Dose)
- Pneumococcal Conjugate Vaccine (7-Valent)-Lenvima (18 MG Daily Dose)
- Pneumococcal Conjugate Vaccine (7-Valent)-Lenvima (20 MG Daily Dose)
- Pneumococcal Conjugate Vaccine (7-Valent)-Lenvima (24 MG Daily Dose)
- Pneumococcal Conjugate Vaccine (7-Valent)-Lenvima (8 MG Daily Dose)